The SURPASS clinical trial program demonstrated that tirzepatide at its highest dose (15 mg weekly) produced average weight loss of 20-25% of body weight, significantly exceeding the results seen with GLP-1 only agonists
Neuroprotective properties of citicoline: facts, doubts and unresolved issues
The anion exchanger PAT-1 (Slc26a6) does not participate in oxalate or chloride transport by mouse large intestine
Increased levels of total lipids, cholesterol, and TG in this study could indicate high lipid peroxidation, which is associated with glycolipid metabolism disorders, loss of cell membrane integrity, and increased energy demand, resulting in cell damage, lipid accumulation, and apoptosis (Saad et al
D.MunozR
10.1016/j.cmet.2017.11.002 384 YuB.PamphlettR